(2) ". . .Fragile X carriers have a high fertility which is even higher in the mentally subnormal patients.
A comprehensive clinical survey of 125 fragile X female carriers, undertaken by Fryns,' was an innovation in clinical studies of this condition. We independently performed a similar study of 113 female heterozygotes, encountered in 44 investigated fragile X families, with generally consistent results. Preliminary results of this study have been published.2 In this paper we extend two particularly important conclusions from the Fryns study by additional data from our investigation which involved much more precise physical and behavioural measures than in the study of Fryns. ' These particular conclusions are as follows.
(1) ". . .At the present time we strongly recommend careful clinical examination of the female relatives of fra(X) males. This seems to provide valuable and definite information with regard to the carrier status in individual women.
(2) ". . .Fragile X carriers have a high fertility which is even higher in the mentally subnormal patients.
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Materials and methods
One hundred and thirteen fragile X females from 44 families were ascertained mainly through probands admitted to genetic counselling clinics (25 families), or through retarded sibs screened for fragile X in special institutions or workshops (13 families). The further five families were ascertained through a single retarded male in a special institution (two) or workshop (three) and one family was diagnosed through a slow learning boy, referred for cytogenetic testing by his school teacher. The standard procedure was to contact families of all the probands, visit them at home, take a detailed family history, and test those affected as well as unaffected male and female relatives who were available and willing to participate in our study. As in the Fryns survey,' family investigations of the proband's female or male relatives involved as many family members as possible. That is to say, we proceeded from a proband and his (or her) sibs to their mother, mother's sibs and their parents, and to their more distant relatives, if they were available and possibly affected with this condition. Thus, our sample of female heterozygotes has been as com-407 D Z Loesch and D A Hay pletely ascertained as is feasible at this time. Fragile X positive subjects or fragile X negative obligate carriers are both listed as carrier females (or female heterozygotes). Their 40 fragile X negative and apparently normal female relatives are also included for comparative purposes. The whole sample of females obtained from fragile X families thus consists of 153 subjects including 91 adult carriers, 22 child carriers, 26 adult 'normal' relatives, and 14 child relatives. In addition, we included data on the number of offspring and miscarriages obtained from a random sample of 107 Australian adult females matched for age, ethnic origin, and socioeconomic status as described by Loesch et al.3 This sample was also used to obtain normal data on facial measurements.
The results of the following testing procedures are presented.
(1) Clinical assessment was based on physical examination, especially recording any major or minor abnormalities, and those unusual facial features commonly encountered in fragile X males. In at least 50% of female subjects clinical investigation was performed without previous knowledge of the result of the cytogenetic test. In all females who were not obviously retarded the clinician (DZIL) was not aware of the results of their psychological assessment at the time of physical examination. We also report information obtained on the number of offspring and frequency of miscarriages. Moreover, several facial measurements, including bizygomatic, bigonial, nose breadth and height, upper and total face height, jaw length, and ear height and breadth, were performed using sliding and spreading calipers. All the measurements were adjusted for age and size and a detailed description of methods has been given elsewhere. Information concerning the sex of aborted fetuses would be important in explaining the observed differences between the number of daughters and sons born alive to female heterozygotes. These estimates may be somewhat biased through including mothers of probands as well as their heterozygous relatives in our fragile X sample. On the other hand, excluding these mothers would bias our estimate in the opposite direction, since our fragile X sample covers the whole range of clinical expression in female heterozygotes. This is because family investigation of relatives of the mothers of probands involved as many members of each family as possible, especially those suspected of having the fragile X condition. Moreover, several types of ascertainment led to the families included in our sample as explained in'previous sections. More specific and less biased information can be obtained from the distribution of the average number of children born to female heterozygotes in each of the four categories of intellectual performance, both verbal (PPVT) and non-verbal (BD), as presented in tests, in the number of children from the mothers in the borderline category; in non-verbal abilities the increase also applies to the mild category. In order to verify whether this is a genuine increase or simply related to a higher proportion of women in the postreproductive age in borderline and mild categories, we have assessed the distribution of age in relation to intellectual status (table 5) . Although the distribution is not random, the proportion of older women (>40 years) is not increased in borderline or mild categories. This rules out the possibility that the observed increase in the total number of children born to carriers with a lesser degree of intellectual impairment can be attributed to the specific age distribution in our sample.
These results are remarkably consistent with the higher reproduction rate in carriers of borderline intelligence observed by Fryns 
